Litigation Details for Novo Nordisk Inc. v. Hikma Pharmaceuticals USA Inc. (D. Del. 2021)
✉ Email this page to a colleague
Novo Nordisk Inc. v. Hikma Pharmaceuticals USA Inc. (D. Del. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-12-20 |
| Court | District Court, D. Delaware | Date Terminated | 2023-01-16 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Parties | HIKMA PHARMACEUTICALS USA INC. | ||
| Patents | 7,762,994; 8,114,833; 8,579,869; 9,265,893 | ||
| Attorneys | James Michael Lennon | ||
| Firms | Devlin Law Firm | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novo Nordisk Inc. v. Hikma Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in Novo Nordisk Inc. v. Hikma Pharmaceuticals USA Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Novo Nordisk Inc. v. Hikma Pharmaceuticals USA Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-12-20 | 1 | Complaint | United States Patent Nos. 8,579,869 (the “’869 patent”), 7,762,994 (the “’994 patent”), 8,114,833 (the… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 7,762,994 25. Novo Nordisk re-alleges… 1. This is an action for patent infringement under the patent laws of the United States, Title…(the “’833 patent”) and 9,265,893 (the “’893 patent”), which cover inter alia, Victoza® and/or its use… THE PATENTS-IN-SUIT 9. On November 12, 2013, the United States Patent and Trademark | External link to document |
| 2022-09-30 | 33 | Notice of Service | ' Invalidity Contentions Regarding U.S. Patent Nos. 8,114,833 and 9,265,893 filed by Novo Nordisk A/S,…2021 17 January 2023 1:21-cv-01783 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-12-20 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,579,869 B2 ;7,762,994 B2 ;8,114,833…2021 17 January 2023 1:21-cv-01783 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-11-08 | 43 | Claim Construction Chart | regarding U.S. Patent Nos. 8,114,833 (the “’833 patent”) and 9,265,893 (the “’893 patent”) (collectively…LITIGATIONS IN U.S. PATENT NO. 8,114,833 Term Affected Claims …LITIGATIONS IN U.S. PATENT NO. 8,114,833 Term Affected Claims …Asserted Patents, the specifications of the Asserted Patents, the claims of the Asserted Patents, the file…of the Asserted Patents, and patents and applications to which the Asserted Patents claim priority or | External link to document |
| 2023-01-16 | 52 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,579,869 B2; 7,762,994 B2; 8,114,833…2021 17 January 2023 1:21-cv-01783 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
